Display options
Share it on

Chonnam Med J. 2020 May;56(2):130-135. doi: 10.4068/cmj.2020.56.2.130. Epub 2020 May 25.

The Impact of Perioperative Use of a Statin-Magnesium Combination on Opioid Consumption in Patients Who Underwent Cardiac Surgery: A Retrospective Study with Propensity-Score Matching.

Chonnam medical journal

Cheol Lee, Cheol Hwan So

Affiliations

  1. Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine, Iksan, Korea.
  2. Department of Pediatrics, Wonkwang University School of Medicine, Iksan, Korea.

PMID: 32509560 PMCID: PMC7250675 DOI: 10.4068/cmj.2020.56.2.130

Abstract

Both statins and magnesium are associated with NMDA receptors and anti-inflammatory effect. Peripheral NMDA receptors are known to be involved in inflammation-induced pain. This study aimed to investigate the impact of perioperative use of a statin-magnesium combination on opioid consumption in patients who underwent cardiac surgery. This was a retrospective study of 542 patients who underwent cardiac surgery. The patients were divided into two groups according to statin use: the statin-magnesium group (n=375) and the magnesium-only group (n=167). Patients in the magnesium-only group received only perioperative magnesium, but no statins, to prevent atrial fibrillation following cardiac surgery. After propensity-score matching, 228 patients (n=114 in each group) were analyzed to investigate opioid consumption, visual analogue scale (VAS) pain scores over a 72-h period, and pain outcomes according to the duration of statin treatment (<1 or ≥1 yr). The consumed opioid volume was significantly smaller in statin-magnesium group than the magnesium-only group, both before (p=0.010) and after matching (p=0.017). The statin-magnesium combination did not significantly reduce the VAS pain scores compared with magnesium alone. Although the statin-magnesium combination did not significantly reduce the pain intensity compared with magnesium alone, the combination therapy was effective in reducing opioid consumption after surgery.

© Chonnam Medical Journal, 2020.

Keywords: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Drug Interactions; Narcotics; Pain Management

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT: None declared.

References

  1. J Anaesthesiol Clin Pharmacol. 2019 Apr-Jun;35(2):242-247 - PubMed
  2. J Neurochem. 2005 Mar;92(6):1386-98 - PubMed
  3. J Pain Res. 2018 Aug 24;11:1599-1611 - PubMed
  4. Eur Heart J. 2012 Aug;33(15):1893-901 - PubMed
  5. Inflammopharmacology. 2010 Aug;18(4):169-77 - PubMed
  6. Minerva Anestesiol. 2018 Apr;84(4):488-503 - PubMed
  7. Front Cardiovasc Med. 2018 Mar 14;5:21 - PubMed
  8. Acta Anaesthesiol Scand. 2008 Nov;52(10):1348-52 - PubMed
  9. Sci Rep. 2017 Aug 30;7(1):10091 - PubMed
  10. BMJ. 2010 May 20;340:c2197 - PubMed
  11. Reg Anesth Pain Med. 2019 Feb;44(2):221-226 - PubMed
  12. Ann Card Anaesth. 2016 Oct-Dec;19(4):687-698 - PubMed
  13. Br J Anaesth. 2017 Oct 1;119(4):803-811 - PubMed
  14. Ann Intensive Care. 2018 Sep 27;8(1):95 - PubMed
  15. BMJ. 2013 Mar 18;346:f880 - PubMed
  16. Br J Anaesth. 2017 Oct 1;119(4):712-715 - PubMed
  17. Pain. 2011 May;152(5):1033-43 - PubMed

Publication Types